LOW-DOSE ADJUNCTIVE BREXPIPRAZOLE IN THE TREATMENT OF BIPOLAR I AND II DEPRESSION: AN OPEN-LABEL STUDY

Registry ID

20-09

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE

Start date

2021-08-03

Last update

2020-10-15

Conditions

• BIPOLAR DEPRESSION

Related clinical trials

• CANNABIDIOL ADJUNCTIVE THERAPY FOR ACUTE BIPOLAR DEPRESSION: A RANDOMIZED DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
• NEUROBIOLOGICAL EFFECTS OF PSILOCYBIN IN TREATMENT RESISTANT BIPOLAR DEPRESSION: AN EMOTIONAL-PROCESSING FMRI PILOT STUDY
• MAINTENANCE KETAMINE INFUSIONS FOR TREATMENT-RESISTANT BIPOLAR DEPRESSION: AN OPEN-LABEL EXTENSION TRIAL
• NEURAL CORRELATES OF ANTI-SUICIDAL RESPONSE TO KETAMINE IN TREATMENT RESISTANT BIPOLAR DEPRESSION (DEEPP-STUDY). PILOT PROJECT
• A MULTIPLE-DOSE, COMPARATIVE BIOAVAILABILITY STUDY OF TWO FORMULATIONS OF QUETIAPINE 400 MG PROLONGED RELEASE TABLETS UNDER FASTING CONDITIONS IN SUBJECTS WITH PRIMARY PSYCHOTIC AND/OR BIPOLAR DISORDER

View on source registry